Table 1. Demographic characteristics of patients with glioblastoma.
| Variables | Number (%) |
|---|---|
| Sex | |
| Male | 30 (60) |
| Female | 20 (40) |
| Age (years) | 54 (range 36-78) |
| KPS | 80 (range 50-100) |
| Histology | |
| Glioblastoma multiforme | 50 (100) |
| Symptoms | |
| Headache | 26 (74) |
| Convulsion | 14 (40) |
| Nausea/vomiting | 22 (63) |
| Motor deficit | 11 (31) |
| Sensitive deficit | 8 (23) |
| Comorbidities | |
| Hypertension | 12 (25) |
| Diabetes | 3 (6) |
| Smoking | 9 (17) |
| Surgery | |
| Total | 30 (60) |
| Partial | 16 (32) |
| Biopsy | 4 (8) |
| Medication | |
| Dexamethasone | 36 (72) |
| Anticonvulsivant | 28 (55) |
| Radiotherapy | |
| Total dose | 60 Gy/30 fractions (range 54-60) |
| FLAIR volume (cm3) | |
| RPA classification | |
| III | 8 (15) |
| IV | 39 (80) |
| V | 3 (5) |
| TMZ+RT | 50 (100) |
| TMZ+RT as planned TMZ+RT interrupted/reduced | 44 (88) 6 (12) |
| Median cycles of adjuvant TMZ | 5 (range 1-7) |
| Follow-up (months) | 22 (range 6-50) |